EP Wealth Advisors LLC Increases Position in Danaher Co. (NYSE:DHR)

by · The Cerbat Gem

EP Wealth Advisors LLC lifted its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 0.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 27,275 shares of the conglomerate’s stock after acquiring an additional 210 shares during the quarter. EP Wealth Advisors LLC’s holdings in Danaher were worth $6,261,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the business. Heck Capital Advisors LLC purchased a new position in Danaher in the fourth quarter valued at approximately $27,000. Decker Retirement Planning Inc. bought a new stake in shares of Danaher in the fourth quarter valued at $31,000. Golden State Wealth Management LLC purchased a new stake in Danaher during the fourth quarter valued at about $31,000. Strategic Financial Concepts LLC bought a new position in Danaher in the 4th quarter worth approximately $31,000. Finally, Pineridge Advisors LLC boosted its holdings in shares of Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 57 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Danaher Price Performance

DHR stock opened at $193.10 on Thursday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The firm has a market cap of $138.19 billion, a P/E ratio of 36.57, a P/E/G ratio of 2.66 and a beta of 0.80. The firm’s fifty day moving average is $198.94 and its 200 day moving average is $220.49. Danaher Co. has a 52 week low of $171.00 and a 52 week high of $281.70.

Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. The firm had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. Research analysts predict that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.66%. Danaher’s payout ratio is 24.85%.

Insider Activity at Danaher

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the company’s stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president now owns 15,179 shares of the company’s stock, valued at $3,005,442. This represents a 51.01 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 11.10% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of brokerages have recently issued reports on DHR. The Goldman Sachs Group lowered their price target on shares of Danaher from $260.00 to $240.00 and set a “neutral” rating on the stock in a report on Wednesday, April 23rd. Jefferies Financial Group reduced their price target on shares of Danaher from $260.00 to $230.00 and set a “buy” rating for the company in a research report on Tuesday, April 22nd. Guggenheim reiterated a “buy” rating and issued a $250.00 price objective on shares of Danaher in a research report on Wednesday, April 23rd. Barclays lifted their price objective on Danaher from $205.00 to $215.00 and gave the company an “overweight” rating in a research note on Tuesday, April 22nd. Finally, Citigroup restated a “buy” rating on shares of Danaher in a research note on Monday, April 7th. Five analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $264.40.

Check Out Our Latest Report on DHR

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Recommended Stories